These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9696609)

  • 1. FDA warns about heartburn drug.
    Josefson D
    BMJ; 1998 Jul; 317(7151):101. PubMed ID: 9696609
    [No Abstract]   [Full Text] [Related]  

  • 2. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1998 Aug; 280(5):410. PubMed ID: 9701062
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical considerations in GERD (gastroesophageal reflux disease) therapy: focus on cisapride.
    Snape WJ
    Am J Manag Care; 1997 May; 3(5):766-71. PubMed ID: 10184748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions.
    Wysowski DK; Corken A; Gallo-Torres H; Talarico L; Rodriguez EM
    Am J Gastroenterol; 2001 Jun; 96(6):1698-703. PubMed ID: 11419817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long QT syndrome during high-dose cisapride.
    Bran S; Murray WA; Hirsch IB; Palmer JP
    Arch Intern Med; 1995 Apr; 155(7):765-8. PubMed ID: 7695465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic profile of cisapride 20 mg after once- and twice-daily dosing.
    Zhou H; Herron J; Clyde C; Lee P; Mechlinski W; Pesco-Koplowitz L
    Clin Ther; 1998; 20(2):292-8. PubMed ID: 9589820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisapride 20 mg b.i.d. provides symptomatic relief of heartburn and related symptoms of chronic mild to moderate gastroesophageal reflux disease. CIS-USA-52 Investigator Group.
    Castell DO; Sigmund C; Patterson D; Lambert R; Hasner D; Clyde C; Zeldis JB
    Am J Gastroenterol; 1998 Apr; 93(4):547-52. PubMed ID: 9576446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NASPGN and ESPGHAN on the use of cisapride.
    Spielberg SP
    J Pediatr Gastroenterol Nutr; 2000 Aug; 31(2):212-3. PubMed ID: 10941984
    [No Abstract]   [Full Text] [Related]  

  • 9. Cisapride in reducing postoperative gastrocaecal transit time after cardiac surgery in children.
    Jenkins IR
    Intensive Care Med; 1997 Apr; 23(4):482-3. PubMed ID: 9142596
    [No Abstract]   [Full Text] [Related]  

  • 10. Cisapride and patient information leaflets.
    Sukkari SR; Sasich LD
    CMAJ; 2001 May; 164(9):1276-8; author reply 1278-9. PubMed ID: 11341134
    [No Abstract]   [Full Text] [Related]  

  • 11. Lessons from cisapride.
    CMAJ; 2001 May; 164(9):1269, 1271. PubMed ID: 11341130
    [No Abstract]   [Full Text] [Related]  

  • 12. Cisapride compared with ranitidine in the treatment of functional dyspepsia.
    Carvalhinhos A; Fidalgo P; Freire A; Matos L
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):411-7. PubMed ID: 7614103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolongation of the QT interval related to cisapride-diltiazem interaction.
    Thomas AR; Chan LN; Bauman JL; Olopade CO
    Pharmacotherapy; 1998; 18(2):381-5. PubMed ID: 9545159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plaintiff's attorney actively seeking out patients who have used various FDA approved medications and who "may be entitled to compensation for damages caused by these medications".
    South D
    J Miss State Med Assoc; 2000 Nov; 41(11):798-9. PubMed ID: 11107716
    [No Abstract]   [Full Text] [Related]  

  • 15. Study with two prokinetics in functional dyspepsia and GORD: domperidone vs. cisapride.
    Halter F; Staub P; Hammer B; Guyot J; Miazza BM
    J Physiol Pharmacol; 1997 Jun; 48(2):185-92. PubMed ID: 9223023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug recalls underscore safety concerns.
    Greene HL
    Health News; 2000 May; 6(5):4. PubMed ID: 10851966
    [No Abstract]   [Full Text] [Related]  

  • 17. Update from the Canadian Dyspepsia Working Group.
    Veldhuyzen van Zanten SJ; Flook N; Chiba N; Armstrong D; Barkun A; Bradette M; Thomson A; Bursey F; Blackshaw P; Frail D; Sinclair P
    CMAJ; 2000 Sep; 163(6):696. PubMed ID: 11022579
    [No Abstract]   [Full Text] [Related]  

  • 18. Syncopal episodes associated with cisapride and concurrent drugs.
    Gray VS
    Ann Pharmacother; 1998 Jun; 32(6):648-51. PubMed ID: 9640482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability of three oral dosage forms of cisapride, a gastrointestinal stimulant agent.
    Barone JA; Huang YC; Bierman RH; Colaizzi JL; Long JF; Kerr DA; Van Peer A; Woestenborghs R; Heykants J
    Clin Pharm; 1987 Aug; 6(8):640-5. PubMed ID: 3691010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long QT interval.
    el-Shafei AG; Bjerregaard P
    Hosp Pract (1995); 1997 Oct; 32(10):36; author reply 39. PubMed ID: 9341632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.